Skip to main content
. 2017 Sep 5;14(5):3985–3992. doi: 10.3892/etm.2017.5101

Table I.

Expression of BCL6, ZEB1 and ZEB2 mRNA in breast cancer and benign breast disease tissue.

BCL6 expression ZEB1 expression ZEB2 expression



Group P-value Total no. of patients n (%) n (%) P-value P-value n (%)
Breast cancer 228 123 (53.9) 0.001 129 (56.6) 0.002 119 (52.2) 0.002
Benign breast disease   80   25 (31.3)   29 (36.3)   26 (32.5)

BCL6, B-cell lymphoma 6; ZEB, zinc finger E-box-binding homeobox.